|
|  |
| NMC II |
|
| Summary of Proposed Investment |
| This Summary of Proposed Investment is prepared and distributed to the public in advance of the IFC Board of Directors’ consideration of the proposed transaction. Its purpose is to enhance the transparency of IFC’s activities, and this document should not be construed as presuming the outcome of the Board decision. Board dates are estimates only. |
| Project number | 26119 |
| Company name | AVA Peter Ltd |
| Country | Russian Federation |
| Sector | Health Care |
| Environmental category | B |
| Department | Health and Education |
| Status | Pending Disbursement |
|
| Date SPI disclosed | August 27, 2007 |
| Projected board date | October 15, 2007 |
| Previous Events | Signed: February 20, 2008
Approved: February 19, 2008 |
|
| View Environmental & Social Review Summary (ESRS), click here |
|
| Overview |
Sponsor/Cost/Location |
Development Impact |
Contacts |
Attachments |
| Project description |
Scanfert Oy, a Finnish holding company currently operates in Russia through OOO Ava Peter and OOO New Medical Center (NMC). Both are leading private providers of healthcare services in St. Petersburg. NMC is an existing IFC client (project #10407). Scanfert Oy has embarked on a five year expansion program in Russia. The proposed project, estimated at a total cost of approximately $49.0 million, comprises the following components of the above expansion program
- Construction and operation of the Primorsky clinic;
- Refurbishment and operation of the Kazan clinic and hospital (public-private partnership);
- Refurbishment and operation of 10 satellite clinics. |
|
| Project sponsor and major shareholders of project company |
| The project sponsors are Dr. Ralph Ashorn and Mr. Gleb Mikhailik, the founders of the Russian operations, operating since 1995. The Sponsors plan to merge the existing Russian operating companies into a new Russian joint stock company which will be the IFC Borrower (NewCo or the Borrower). While the final shareholding structure of the NewCo is not yet determined, the sponsors will have majority control. |
| Total project cost and amount and nature of IFC's investment |
| The proposed project is estimated at a total cost of approximately $49.0 million. Proposed IFC investment will include a RUB A Loan of up to $13 million equivalent, a RUB B Loan of up to $13 million equivalent and a possible equity investment of up to $4 million equivalent for IFC’s own account. |
| Location of project and description of site |
| The ten satellite clinics will be located in rented facilities in various districts of St. Petersburg, Russia. To date, three clinics have been opened in the Vyborgsky, Kirovsky and Primorsky districts of the city. The Primorsky clinic will cover a total area of 16,500 m2 in a Greenfield 5-7 story building. The Kazan clinic and hospital will be located in an existing building in central Kazan, in the Tartarstan region of Russia. |
|
| Anticipated development impact of the project |
| Supporting the expansion of the company in Russia will have a strong development impact by widening access to quality healthcare, particularly services not commonly available e.g. infertility services, and establishing benchmarks for administrative and patient care practices in the country’s nascent private health sector. |
 |
| IFC's expected development contribution |
| IFC’s main role is as a provider of flexible, long-term financing, attractively priced in a market where there is limited investor appetite for investment in private health sector in Russia at good terms. IFC also has the opportunity to provide certain value-added services and advice requested by the client – financial and accounting management, restructuring and merger negotiations, insurance coverage and corporate governance. IFC will also be supporting the first health public private partnership in Kazan. |
| Environmental and social issues - Category B |
This project, a repeat investment, is being reviewed as a direct investment according to IFC's Social and Environmental Sustainability Policy. Based on a review of project information, site visits and meetings with the sponsor, the following Performance Standards (PS) are deemed to be applicable:
- PS1: Social and Environmental Assessment and Management Systems with respect to corporate environmental, social, hygiene and health and safety management systems, including national and local government permitting requirements;
- PS2: Labor and Working Conditions including occupational health and safety and training programs for employees and third party construction workers;
- PS3: Pollution Prevention and Abatement including particularly waste management;
- PS4: Community Health, Safety and Security including fire and life safety, emergency response, and community consultation and disclosure;
- PS8: Cultural Heritage with respect to the redevelopment of medical facilities in the city of Kazan.
IFC will determine the extent of any gaps in the above Performance Standards and the client will address these via appropriate Action Plans. The existing investment has excellent environmental and social performance. |
|
| For inquiries about the project, contact: |
Dr. Ralph Ashorn, Chief Executive Officer
Scanfert Oy Ltd
Keskustori 1 A 10
FIN-33100
Tampere, Finland
Telephone: + 358-400-639-480
Fax: + 358-3-3392-6510
E-mail: Ralph.ashorn@avaclinic.com
The location of the environmental documents is as follows:
Mr.Gleb Mikhailik, Director General
55-A, Liteyny Avenue
Saint Petersburg, Russia
191014 |
|
| For inquiries and comments about IFC, contact: |
General IFC Inquiries
IFC Corporate Relations
2121 Pennsylvania Avenue, NW
Washington DC 20433
Telephone: 202-473-3800
Fax: 202-974-4384
E Mail: Webmaster |
|
|
|
|